Logo image of ANRG.CA

ANAERGIA INC-SUB VOTING SHR (ANRG.CA) Stock Fundamental Analysis

TSX:ANRG - Toronto Stock Exchange - CA03253E2069 - Common Stock - Currency: CAD

1.17  +0.01 (+0.86%)

Fundamental Rating

2

Taking everything into account, ANRG scores 2 out of 10 in our fundamental rating. ANRG was compared to 23 industry peers in the Commercial Services & Supplies industry. ANRG has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ANRG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ANRG has reported negative net income.
ANRG had a negative operating cash flow in the past year.
ANRG had negative earnings in 4 of the past 5 years.
ANRG had negative operating cash flow in 4 of the past 5 years.
ANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M

1.2 Ratios

The Return On Assets of ANRG (-22.53%) is worse than 82.61% of its industry peers.
Industry RankSector Rank
ROA -22.53%
ROE N/A
ROIC N/A
ROA(3y)-24.97%
ROA(5y)-15.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANRG.CA Yearly ROA, ROE, ROICANRG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 100 200 300

1.3 Margins

Looking at the Gross Margin, with a value of 19.72%, ANRG is doing worse than 60.87% of the companies in the same industry.
In the last couple of years the Gross Margin of ANRG has declined.
The Profit Margin and Operating Margin are not available for ANRG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.96%
GM growth 5Y-12.19%
ANRG.CA Yearly Profit, Operating, Gross MarginsANRG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

ANRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
ANRG has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ANRG has an improved debt to assets ratio.
ANRG.CA Yearly Shares OutstandingANRG.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M
ANRG.CA Yearly Total Debt VS Total AssetsANRG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -2.56, we must say that ANRG is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ANRG (-2.56) is worse than 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.56
ROIC/WACCN/A
WACC4.7%
ANRG.CA Yearly LT Debt VS Equity VS FCFANRG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

ANRG has a Current Ratio of 1.20. This is a normal value and indicates that ANRG is financially healthy and should not expect problems in meeting its short term obligations.
ANRG has a Current ratio (1.20) which is in line with its industry peers.
ANRG has a Quick Ratio of 1.11. This is a normal value and indicates that ANRG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ANRG (1.11) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.11
ANRG.CA Yearly Current Assets VS Current LiabilitesANRG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

ANRG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -193.88%.
Looking at the last year, ANRG shows a decrease in Revenue. The Revenue has decreased by -9.62% in the last year.
Measured over the past years, ANRG shows a quite strong growth in Revenue. The Revenue has been growing by 18.32% on average per year.
EPS 1Y (TTM)-193.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.25%
Revenue 1Y (TTM)-9.62%
Revenue growth 3Y10.04%
Revenue growth 5Y18.32%
Sales Q2Q%1.94%

3.2 Future

Based on estimates for the next years, ANRG will show a very strong growth in Earnings Per Share. The EPS will grow by 46.67% on average per year.
Based on estimates for the next years, ANRG will show a very strong growth in Revenue. The Revenue will grow by 89.33% on average per year.
EPS Next Y92.56%
EPS Next 2Y38.89%
EPS Next 3Y46.67%
EPS Next 5YN/A
Revenue Next Year-26.8%
Revenue Next 2Y-5.48%
Revenue Next 3Y89.33%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ANRG.CA Yearly Revenue VS EstimatesANRG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ANRG.CA Yearly EPS VS EstimatesANRG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ANRG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANRG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANRG.CA Price Earnings VS Forward Price EarningsANRG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANRG.CA Per share dataANRG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

ANRG's earnings are expected to grow with 46.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.89%
EPS Next 3Y46.67%

More info and screens

0

5. Dividend

5.1 Amount

ANRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANAERGIA INC-SUB VOTING SHR

TSX:ANRG (5/1/2025, 7:00:00 PM)

1.17

+0.01 (+0.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)N/A N/A
Inst Owners4.09%
Inst Owner ChangeN/A
Ins Owners17.43%
Ins Owner ChangeN/A
Market Cap198.71M
Analysts42.22
Price Target1.33 (13.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-41.2%
Min Revenue beat(2)-44.27%
Max Revenue beat(2)-38.13%
Revenue beat(4)0
Avg Revenue beat(4)-33.56%
Min Revenue beat(4)-44.27%
Max Revenue beat(4)-13.81%
Revenue beat(8)1
Avg Revenue beat(8)-24.32%
Revenue beat(12)1
Avg Revenue beat(12)-22.55%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)30%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.78
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.88
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.66
BVpS-0.32
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.53%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.72%
FCFM N/A
ROA(3y)-24.97%
ROA(5y)-15.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.96%
GM growth 5Y-12.19%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 120.19%
Cap/Sales 5.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 1.11
Altman-Z -2.56
F-Score4
WACC4.7%
ROIC/WACCN/A
Cap/Depr(3y)2102.96%
Cap/Depr(5y)2535.14%
Cap/Sales(3y)55.51%
Cap/Sales(5y)69.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-193.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.25%
EPS Next Y92.56%
EPS Next 2Y38.89%
EPS Next 3Y46.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.62%
Revenue growth 3Y10.04%
Revenue growth 5Y18.32%
Sales Q2Q%1.94%
Revenue Next Year-26.8%
Revenue Next 2Y-5.48%
Revenue Next 3Y89.33%
Revenue Next 5YN/A
EBIT growth 1Y46.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.33%
EBIT Next 3Y89.13%
EBIT Next 5YN/A
FCF growth 1Y67.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.45%
OCF growth 3YN/A
OCF growth 5YN/A